Presented by


Endorsed by




Apheresis News Volume 3.02

Apheresis News facilitates the exchange of information and resources between members of the global apheresis community by providing a website portal and free, bi-monthly e-newsletter dedicated to the latest information affecting apheresis.

                                                          Subscribe | Unsubscribe

February 6, 2008  // Volume 3.02
TOP STORY
Gambro BCT and Fenwal Suspend PASSPORT Post-Market Surveillance Study for 7-Day Platelets
Gambro BCT, Inc. and Fenwal, Inc. have announced their decision to suspend the PASSPORT (Post Approval Surveillance Study of Platelet Outcomes, Release Tested) Study for 7-day platelet storage. This action is being taken as a precautionary measure in the interest of patient safety while Gambro BCT and Fenwal collaborate with the U.S. Food and Drug Administration to explore modifications to the PASSPORT study.

SCIENCE

Australian Girl Switches Blood Type After Liver Transplant
An Australian girl spontaneously changed blood groups and adopted her donor's immune system after a liver transplant.

Blood's Hydrodynamics Used To Manipulate Stem, Cancer Cells
A tiny, implantable device has pulled adult stem cells out of a living rat with a far greater purity than any present technique.

Engineered Blood May Help Bird Flu Fight
Blood taken from ordinary donors and engineered to recognise the H5N1 bird flu virus was able to protect mice from several strains of the disease, a researcher at Dutch biotechnology firm Crucell said on Friday.

Iran-made Glue to Replace Stitches
The Iranian Blood Transfusion Organization has used human blood plasma to produce fibrin glue which can replace surgical stitches.

AngioDynamics Highlights Results From Preliminary Study of Centros(TM) Central Venous Catheter for Hemodialysis
AngioDynamics highlighted results from a United States preliminary study of Centros(TM), a self-centering, tunneled hemodialysis access catheter.

Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R)
The pivotal trial is a multi-centered, randomized study evaluating the efficacy and safety of Zuragen(R) for the prevention and treatment of catheter-related bloodstream infection (CRBSI) in end-stage renal disease patients requiring the use of a tunneled central venous catheter for hemodialysis compared to heparin, the current standard of care.

Smiths Medical Receives 510(k) Clearance on Saf-T Closed Blood Collection System(R) Devices 
Smiths Medical, ASD, Inc. announced that it has received 510(k) clearance from the U.S. Food & Drug Administration for its Saf-T Closed Blood Collection System(R) for use in syringe blood draw and transfer applications. Configurations address winged vein access as well as Luer access to a newly placed peripheral IV catheter.

SJSU Suspends Blood Drives, Citing FDA Ban on Donations by Gay men
In a controversial move believed to be a first by an American college, San Jose State University President Don Kassing has suspended all campus blood drives because of a longstanding government policy that bars gay men from donating blood.

Fatal Transfusion Reaction Report Released 
Contamination from condensation on foam boxes containing blood bags might have caused a Tuen Mun Hospital patient's fatal transfusion reaction on January 7, an investigation panel has found.

Blood Bank Scraps Pricey Computer System
The Irish Blood Transfusion Service has scrapped a new computer system for the safety and tracing of blood products.

International Apheresis Registry
The International Apheresis Registry is open and collecting data.  If you have participated in the past, we thank you for your valuable data and encourage you to enter your data for 2007.  If you have not participated in the registry recently, this is a good opportunity to get your data included in the registry.  The results of this study will be presented at the 7th World Congress of the International Society for Apheresis (ISFA) to be held in 2009 and published in Therapeutic Apheresis and Dialysis. The purpose of the study is to update past registry statistics to highlight clinical apheresis practices at an international level and to further assess results to determine emerging trends as well as the efficacy and clinical outcomes of apheresis therapies.
 
For an example of the prior International Apheresis Registry results, please see:
Malchesky PS, Koo AP, Roberson GA, Hadsell AT, Rybicki LA.  Apheresis technologies and clinical applications: The 2005 International Apheresis Registry. Ther Apher Dial 2007; 11:341-62.
 
For more information, please contact the International Apheresis Registry at:
Tel: +(440)358-1102, Fax: +(440)358-1104, E-mail: Artiforgs@aol.com

ABSTRACTS, REVIEWS AND SPECIAL REPORTS 

Twice-daily Plasma Exchange for Patients with Refractory Thrombotic Thrombocytopenic Purpura: The Experience of the Oklahoma Registry, 1989 Through 2006
In three patients, twice-daily plasma exchange appeared to be beneficial. In most patients, a benefit of twice-daily plasma exchange could not be clearly documented because other treatments were initiated or intensified.

Structural Epitope Matching for HLA-alloimmunized Thrombocytopenic Patients: A New Strategy to Provide More Effective Platelet Transfusion Support?
An HLA epitope–based matching protocol is proposed that may permit a more effective platelet transfusion management of refractory patients.


BUSINESS

Delcath and Aethlon Medical Sign Collaboration Agreement to Research and Develop Advanced Filtration Technology
Aethlon Medical, Inc. and Delcath Systems, Inc. have announced a collaboration to jointly research and develop an advanced filtration cartridge for potential use in Delcath Systems' percutaneous hepatic perfusion system.

Link Plus Forms Subsidiary to Develop MIPs-Based Solutions for Detection and Filtering of Viruses for Public Health Applications
Link Plus Corporation announced today that it has formed a subsidiary called Link Plus BioTech, Inc. to focus on public health related applications of Molecularly Imprinted Polymers (MIPs) technology for the specific detection, binding, and separation of viruses.

Biomérieux and Shanghai Kehua Bio-Engineering Build Joint Venture 
Shanghai Kehua Bio-engineering and bioMérieux announce the creation of a Shanghai-based joint venture to which bioMérieux will transfer microplate immunoassay manufacturing currently located at its Boxtel site in the Netherlands.

AcroMetrix Renews Contract With Group Services for America's Blood Centers
AcroMetrix has announced that it will extend its contract with Group Services for America's Blood Centers through December 31st of 2009.

ProMetic Announces Scale-up of Prion Removal Resin in Plasma Product for Biopharmaceutical Use
ProMetic Life Sciences Inc. announces that its UK-based subsidiary, ProMetic BioSciences Ltd, has successfully completed the first phases of development utilizing Pathogen Removal and Diagnostic Technologies Inc.'s ligand technology for prion binding and removal from a plasma product for biopharmaceutical use marketed by a major European plasma fractionator.

Portugal to Introduce a Bundled Rate for Hemodialysis Treatment
Fresenius Medical Care AG & Co. KGaA has announced that the Portuguese Ministry of Health and Anadial, the national association of privately run dialysis centers, agreed on a new reimbursement model for ambulatory care to hemodialysis patients.

Aethlon Medical Files Blood Contaminant Patent
Aethlon Medical, Inc. has disclosed that it has filed a provisional patent submission entitled, "Method and Apparatus for Increasing Contaminant Clearance Rates during Extracorporeal Fluid Treatment," with the U.S. Patent and Trademark Office.

Health Quest Chooses Cerner for Healthcare IT
Health Quest, the largest healthcare system in New York’s Hudson Valley, has selected Cerner as its clinical information systems solution provider. Health Quest will implement a suite of Cerner Millennium(R) clinical solutions throughout its system of three hospitals.

Brad Nutter Named Chairman of the Board of Haemonetics
Haemonetics announced today the decision by its Board of Directors to expand the role of current Chief Executive Officer Brad Nutter to a newly created position that combines the roles of CEO and Chairman of the Board. Mr. Nutter's promotion is effective immediately.


FUNDING & PROGRAMS
Additional Receipt Dates and Salary Change for RFA-DK-06-015, NIDDK Mentored Clinical Scientist Award to Promote Diversity in Health-Related Research (K08) (NOT-DK-08-007)
REGULATORY

California Paul Gann Blood Safety Act Amended


FOOD AND DRUG ADMINISTRTRATION (United States of America)

Urgent Product Recall - Heparin Sodium Injection 1000 units/mL 10mL and 30 mL Vials

Variances for Collection of Blood and Blood Products from Patients with Hemochromatosis 

Request for Notification from Industry Organizations Interested in Participating in the Selection Process for a Nonvoting Industry Representative on the Blood Products Advisory Committee and Request for Nominations for a Nonvoting Industry Representative on the Blood Products Advisory Committee


CENTERS FOR MEDICARE AND MEDICAID SERVICES (United States of America)

March 1st is a Critical Date!
As of March 1, 2008: Claims with both an NPI and a Medicare legacy number will continue to be rejected if the pair is not found on the Medicare NPI Crosswalk. Claims without an NPI in the primary provider field will be rejected! Claims with only a Medicare legacy number in the primary provider field will be rejected!


THE JOINT COMMISSION (United States of America)

Potential 2009 National Patient Safety Goal (NPSG) Requirements and Implementation Expectations


MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (United Kingdom)

Conference Info - Revision of Medical Device Directives


NATIONAL ACCREDICATION BOARD FOR HOSPITALS AND HEALTHCARE PROVIDERS (India)

The National Accreditation Board for Hospitals and Healthcare Providers (NABH) Launches Accreditation Standard Programme for Blood Banks and Transfusion Services


ASFA

ASFA 2008 Educational Webinar Series

ASFA is pleased to announce the continuation of the 2008 series of ASFA educational webinars addressing various aspects and applications of clinical and therapeutic apheresis in both donor and patient settings.
Registration is now open! Please visit the ASFA website at www.apheresis.org for more information about ASFA webinars and to register today!

ASFA 2008 Annual Meeting

Early Discounted Registration Deadline is February 27, 2008

The ASFA 2008 Annual Meeting will be held in Galveston, from April 9 - 12, 2008 at the Galveston Island Convention Center at the San Luis Resort.

Be sure to register before February 27, 2008 to take advantage of the early registration fees.

The ASFA 2008 Annual Meeting Preliminary Program is also available to view and download from the Society's website, www.apheresis.org.

We look forward to seeing you in Galveston!

Register for the Clinical and Technical Rounds

Participate in a clinical and technical round table discussion with experts in the field. As seats are limited to 10 participants for each table, register early as seats are assigned on a 'first come, first served' basis. Please note that you must register online on the ASFA website at www.apheresis.org

Make Your Hotel Reservation

Early bookings have filled the room block at the San Luis Resort, Spa and Conference Center and the Hilton Galveston Island Resort.  This means that there is one conference-rate hotel currently available to ASFA delegates: The Holiday Inn on the Beach. The Holiday Inn is part of the San Luis Resort complex and is within easy walking distance to the Galveston Island Convention Center, the conference venue. Make your hotel reservation today!

Special Rate Deadline: March 14, 2008

JOB OPPORTUNITIES

Apheresis/Infusion Nurse
ProHEALTH Care Associates

Therapeutic Apheresis Nurses Needed!
American Red Cross

RN w/ BSN - Technical Coordinator
University Hospitals Case Medical Center

Medical Liaison
Palm Isle Search Consultants


CAREER FAIR

Apheresis Career Fair at the ASFA 2008 Annual Meeting

Are you interested in recruiting for an apheresis-related position for your company or institution?

The inaugural Apheresis News and ASFA Career Fair is the perfect opportunity to highlight your organization, profile open positions, and recruit highly qualified apheresis professionals from a captive audience of over 700 delegates at the ASFA 2008 Annual Meeting and to over 4,000 recipients of Apheresis News.

Enhanced Career Posting Package ($500)

Job postings will receive the following profile:

  • An exclusive webpage on the Apheresis News website, and posting on ASFA’s career webpage
  • Distribution via email to all ASFA members, ASFA annual meeting delegates, and Apheresis News subscribers
  • Inclusion in ASFA 2008 Annual Meeting delegate bags in a special print issue of the ASFA Newsflash


Career Fair Sponsor ($1000)

Career Fair Sponsors receive the following benefits:

  • Enhanced Career Posting Package
  • 1 table top exhibit space in the Exhibit Hall at the ASFA 2008 Annual Meeting exclusively for recruitment purposes
  • Opportunity to meet with potential candidates in a semi-private room setting

To take advantage of this offer, complete the Apheresis Career Fair Application Form and send, along with payment information, via email to asfa@apheresis.org or via fax to 604.874.4378.


FEATURED EVENT
34th Annual Meeting of the European Group for Blood and Marrow Transplantation
March 30 – April 2, 2008
Florence, Italy

This newsletter is intended to be a useful and timely reference for those working or interested in apheresis. Because of the constantly changing nature of the Internet, some of the website links included herein may change without notice.
Subscribe | Unsubscribe 
 
Connexon Creative Inc. 375 West 5th Avenue, Suite 201, Vancouver, B.C. V5Y 1J6  
p. 604.630.5515  e. info@apheresisnews.com
Privacy Policy